cdmo.directory
← Compare landing

Asimov vs BioInnovatise

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAsimovBioInnovatise
SummaryAsimov provides cell line development, upstream process development, and viral vector manufacturing services powered by proprietary synthetic biology platforms (CHO Edge, LV Edge, AAV Edge, RNA Edge) that deliver high-titer, stable cell lines and production systems for biologics, cell therapies, and gene therapies.BioInnovatise provides fast, reliable CDMO services for plasmid DNA, viral vector packaging, and CRISPR-Cas9 research with turnaround times of 7–28 days.
Services
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Discovery Research
  • Translational Research
  • Cell-Line Development
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Development capabilities
  • Analytical method development
  • Cell line development
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Max bioreactor: Mid-scale clinical (≤2,000 L)
  • Expression: Mammalian
  • Expression: Cell-Free
  • Single-Use / Disposable
  • Expression: Mammalian
  • Expression: Cell-Free
Locations
  • Headquarters, Boston, MA, USA
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Asimov alternatives · BioInnovatise alternatives

Markdown mirror: /compare/asimov/bioinnovatise.md